Corona virus Vaccine Trial
now browsing by tag
Untimely results from Moderna coronavirus vaccine assessment show participants succeeded antibodies against the virus
*Volunteers who received Moderna’s Covid-19 vaccine had positive early results, according to the biotech company, which partnered with the National Institutes of Health to develop the vaccine.*
If future findings end up well, the company’s vaccine could be in the doorstep of the public as early as January, Dr. Tal Zaks, Moderna’s chief medical officer, told CNN.
“This is absolutely good news and news that we think many have been waiting for for quite some time,” Zaks said.
These untimely data come from the Phase 1 clinical test, which typically studies a small number of people and focuses on whether a vaccine is reliable and elicits an immune response or not.
The results of the study, which was led by the National Institutes of Health, have not been peer write up or published in a medical journal yet.
Amidst the medical race to discover an helpful vaccine for the coronavirus that is currently escalating across the world, The Gambia Scientists’ Association, a group of nine home-based scientists, have asserted they are about to test some vaccines for the Covid-19.
Suwaebou Jammeh, the president of the association told The Standard yesterday that three different vaccines are now ready to be try-out
“Just like our fellow scientists around the world, when the coronavirus outbreak was reported we decided to mobilise our efforts to see how best we could secure a vaccine. As we speak, we have discovered three different vaccines which are set for testing and we hope one of them will be effective for Covid-19,” he said.
Nonetheless, Mr Jammeh added: “We want to make it very clear that these vaccines have not been tested yet. We cannot confirm that they will be effective but we are very confident that one of them will be. We just did what scientists around the world are doing. We know we are not certified to make medicine but we are trying to engage the Ministry of Health to see whether they are interested to test the vaccine and see whether it is effective or not.”
For the moment, Senegalese scientific committee has affirmed the effectiveness of the Malagasy remedy and gives the green light for its use in Senegal.
*After receiving a sample of the COVID-19 organics of a Malagasy remedy for the coronavirus, Senegalese scientists said that clinical trials have approved the effectiveness of the remedy.*
Professor Daouda Ndiaye talking to Radio Futurs Medias (RFM) said the Professor Epidemiologist and Head of the Parasitology-Mycology Service of the University Cheikh Anta Diop of Dakar made known the effectiveness of the Malagasy remedy.
“We are moving towards the use of artemisia (Covid-19 Organics). On our side on the scientific level, our light is green […]. We are going to organize ourselves to see how we can reproduce the same formula or order the remedy to give it to the Senegalese,”said Daouda Ndiaye.